United States · FDA National Drug Code directory
Flecainide Acetate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 53746-641_e9e0eab5-efc5-4bac-8d46-0bce60b2fcc5
- Product NDC
- 53746-641
- Form
- TABLET
- Composition / generic term
- Flecainide Acetate
- Labeler
- Amneal Pharmaceuticals of New York LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20091201
- Source listing expiry
- 20271231
Source-listed ingredients
- FLECAINIDE ACETATE — 50 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (53746-641-01) · 53746-641-01
- 1000 TABLET in 1 BOTTLE (53746-641-10) · 53746-641-10
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →